|
Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 Clinical research trials and Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1. Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 clinical trial. Test subjects typically obtain the finest healthcare available for their Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1  Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
For Condition: Substance-Related Disorders
Status: Recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Details: Participants seeking treatment at the participating CTPs will be randomly assigned to either "standard" or "MET/MI" treatment, with a 1- and 3-month follow-up. Primary outcome measures will include (1) treatment retention (e.g., number of sessions/weeks completed, the rate of patients completing 3 or more subsequent sessions, and (2) substance use (e.g., urinalyses, days of opioid, cocaine, marijuana, alcohol use, rates of abstinence). Secondary outcomes will include motivation, psychosocial functioning, HIV risk behaviors, treatment utilization, and patient satisfaction. Process assessments will include measures of the working alliance as well as therapist adherence/competence ratings which will evaluate how effectively MET/MI was implemented. Participating CTPs will implement one of two independent protocols, depending on which is the best suited or feasible for the intake procedures at their clinic. Thus, following an invitation to participate, explanation of the study, and provision of informed consent, patients would complete a brief assessment battery followed by either: 1) Random assignment to 3 individual sessions of standard treatment (treatment as usual) at the program versus 3 individual sessions of MET. or 2) Random assignment to 1 individual standard assessment/evaluation session.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Uncontrolled
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Individuals will be eligible for the protocol who: - Are seeking outpatient treatment for any substance use disorder - Are 18 years of age or older - Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped) - Are able to understand and provide written informed consent Exclusion Criteria: Individuals will be excluded who: - Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment - Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment
Total Enrollment: 600
Location and Contact Information:
Overall Study Official:
KathleenCarroll, Principal Investigator, VA Connecticut Healthcare System
LMG Programs, Inc. *Recruiting*
Stamford, Connecticut, 06901
United States
Recruiting Tina Klem 203-356-1980
Rehab After Work *No longer recruiting*
Philadelphia, Pennsylvania, 19103
United States
No longer recruiting
Tarzana Treatment Center *No longer recruiting*
Tarzana, California, 91356
United States
No longer recruiting
Haight Ashbury Free Clinics *Terminated*
San Francisco, California, 94117
United States
Terminated
Northeast Treatment Center *No longer recruiting*
Philadelphia, Pennsylvania, 19123
United States
No longer recruiting
CT Renaissance, Inc. *No longer recruiting*
Norwalk, Connecticut, 06852
United States
No longer recruiting
Additional Information:
Study ID Numbers: NIDA-CTN-0004-1;
Study Start Date: April 2001
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00032981
Other Substance-Related Disorders Studies:
1. Substance Dependent Teens - Impact of Treating Depression Study 1 - 1
2. Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
3. Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
4. Effects of Combined Alcohol and Nitrous Oxide Intake - 15
5. Effects of Buprenophine and Naloxone in Opite Addicts - 4
Related Studies:
Other Substance-Related Disorders Clinical Trials
Other Connecticut Clinical Trials
Other Stamford Clinical Trials
Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
|
|
|
|
|
|
|
|
